Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand

Journal of Immunology

Volumn 159, Issue 5, 1997, Pages 2108-2115

  Zipp, Frauke ^a   Martin, Roland ^a,b   Lichtenfels, Rudolf ^a   Roth, Wilfried ^a   Dichgans, Johannes ^a   Krammer, Peter H ^c   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BAX PROTEIN, HUMAN; BCL2L1 PROTEIN, HUMAN; FAS ANTIGEN; FAS LIGAND; FASLG PROTEIN, HUMAN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; ONCOPROTEIN; PREDNISOLONE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BIOSYNTHESIS; CELL CULTURE; CYTOTOXICITY; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; GLIOMA; HUMAN; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; NEUROBLASTOMA; PATHOLOGY; PHYSIOLOGY; T CELL LEUKEMIA; T LYMPHOCYTE SUBPOPULATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD95; APOPTOSIS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; DRUG RESISTANCE; FAS LIGAND PROTEIN; GENE EXPRESSION REGULATION; GLIOMA; HUMANS; LEUKEMIA, T-CELL, ACUTE; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MULTIPLE SCLEROSIS; NEUROBLASTOMA; POLY(ADP-RIBOSE) POLYMERASES; PREDNISOLONE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; T-LYMPHOCYTE SUBSETS; TUMOR CELLS, CULTURED;

EID: 0031227661     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Owen-Schaub, L., S. Yonchara, W. L. Crump III, and E. A. Grimm. 1992. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell. Immunol. 140:197.
2. Russell, J. H., C. L. White, D. Y. Loh, and P. Meleedy-Rey. 1991. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc. Natl. Acad. Sci. USA 88:2151.
3. Wesselborg, S., O. Janssen, and D. Kabelitz. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150:4338.
4. Klas, C., K. M. Debatin, R. R. Jonker, and P. H. Krammer. 1993. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5:625.
5. Dhein, J., H. Walczak, C. Bäumler, K. M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 373:438.
6. Brunner, T., R. J. Mogil, D. LaFace, N. J. Yoo, A. Mahboubl, F. Echeverri, S. J. Martin, W. R. Force, D. H. Lynch, C. F. Ware, and D. R. Green. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature 373:441.
7. Ju, S. T., D. J. Panka, H. Cui, R. Ettinger, M. El-Khatib, D. H. Sherr, B. Z. Stanger, and A. Marshak-Rothstein. 1995. Fas (CD95)/FasL interactions required for programmed cell death after T cell-activation. Nature 373:444.
8. Alderson, M. R., T. W. Tough, T. Davis-Smith, S. Braddy, B. Falk, K. A. Schooley, R. G. Goodwin, C. A. Smith. F. Ramsdell, and D. H. Lynch. 1995. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. Exp. Med. 181:71.
9. Van Parijs, L., A. Ibraghimov, and A. K. Abbas. 1996. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 4:321.
10. Miyawaki, T., T. Uehara, R. Nibu, T. Tsuji, A. Yachie, S. Yonehara, and N. Taniguchi. 1992. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J. Immunol. 149:3753.
11. Suda, T., T. Takahashi, P. Golstein. and S. Nagata. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169.
12. Tanaka, M., T. Suda, T. Takahashi, and S. Nagata. 1995. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1129.
13. Tanaka, M., T. Suda, K. Haze, N. Nakamura, K. Sato, F. Kimura, K. Motoyoshi, M. Mizuki, S. Tagawa, S. Ohga, K. Hatake, A. H. Drummond, and S. Nagata. 1996. Fas ligand in human serum. Nat. Med. 2:317.
14. Mariani, S. M., B. Matiba, C. Bäumler, and P. H. Krammer. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 25:2303.
15. Kayagaki, N., A. Kawasaki, T. Ebata, H. Ohmoto, S. Ikeda, S. Inoue, K. Yoshino, K. Okumura, and H. Yagita. 1995. Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 182:1777.
16. Nagata, S., and P. Golstein. 1995. The Fas death factor. Science 267:1449.
17. Martin, R., H. F. MeFarland, and D. E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.